Skip to main content

Table 1 Clinical and demographic data for patients with rheumatoid arthritis (RA)

From: Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission

 

Active RA (n = 22)

Remission RA (n = 20)

P value

Female, n (%)

16 (72.7)

15 (75)

0.867

Age, years, mean (SD)

58.8 (9.6)

53.7 (10.8)

0.346

Disease duration, years, mean (SD)

12.5 (9.8)

8.5 (8.2)

0.001

Rheumatoid factor+, n (%)

14 (63.6)

11 (55)

0.569

ACPA+, n (%)

15 (68.1)

18 (90)

0.085

DAS28-ESR, mean (SD)

5.41 (1.30)

1.92 (0.32)

0.001

Biological therapy, n (%)

14 (63.6)

10 (50)

0.231

Prednisone, n (%)

18 (81.8)

2 (10)

0.0001

DMARDs, n (%)

20 (90.9)

16 (80)

0.881

Biopsy location

   

MCP, n (%)

0 (0)

3(15)

Wrist, n (%)

4 (18.1)

13 (65)

Knee, n (%)

18 (81.8)

4 (20)

PD, n (%)

22 (100)

20 (100)

 

PD ≥2, n (%)

22(100)

3 (15)

SH ≥2, n (%)

22 (100)

16 (80)

 

SH ≥2 + PD, n (%)

22 (100)

16 (80)

 
  1. SD standard deviation, ACPA anti-cyclic citrullinated peptide/protein antibody, DAS28 28-joint Disease Activity Score, ESR erythrocyte sedimentation rate, DMARD disease-modifying antirheumatic drug, MCP metacarpophalangeal joint, PD power Doppler, SH synovial hypertrophy